Our reports provide evidence that helps to build awareness and support pioneering dementia research in the UK and globally.
Tipping Point: The Future of Dementia
September 2023
Our new report sets out a series of calls for party leaders ahead of the next general election. We believe these recommendations are vital to tackle the increasing pressure that dementia places on society, the NHS, and the economy.
Investing in dementia research boosts UK economy
July 2023
If nothing changes, one in two of us will be directly affected by dementia, either by developing the condition ourselves, caring for someone, or both.
Addressing value and affordability
July 2022
Following a workshop with stakeholders from the NHS, the National Institute for Health and Care Excellence (NICE), industry and academia, we examine the challenges and opportunities in assessing the value and affordability of new Alzheimer’s medicines.
Establishing a Clinical Trials Network
May 2023
The creation of a ‘clinical trials network’ has huge potential to dramatically change the landscape for dementia research in the UK. Here, we set out our recommendations for how such a network could operate and deliver successful outcomes.
A joint statement on the voluntary scheme for branded medicines pricing and access (VPAS)
March 2023
Patient charities set out a shared vision for the next VPAS scheme.
Improving dementia diagnosis: what could change in primary care?
November 2022
The search for life-changing dementia treatments is beginning to yield tangible results. Now is the time for primary care to adapt to diagnosing people at the earliest stages of dementia, when treatments are most likely to be effective.
Five steps to delivering life-changing treatments for dementia
August 2022
Alzheimer’s Research UK is calling on the new Prime Minister to follow five key steps to ensure the UK can be a world leader in dementia clinical research and help deliver life-changing treatments.
The Impact of Dementia on Women
May 2022
Dementia devastates the lives of everyone it touches, but our analysis shows that women are bearing a disproportionate weight of the impact.
Dementia Attitudes Monitor: Wave 2 (2021)
September 2021
Wave 2 builds on findings from Wave 1 (2018), shining a light on the UK’s attitudes towards dementia.
Are we ready to deliver disease modifying treatments?
May 2021
Old Age Psychiatrists’ views on diagnosing and treating Alzheimer’s disease before dementia
The Right to Know: Accurate and Earlier Diagnosis of Dementia
May 2021
Our vision of how to progressively reform and build dementia diagnostics capability in the UK.
Translating Science into breakthroughs: the future of late-stage dementia clinical trials in the UK
May 2021
People with dementia are at risk of missing out on new treatments if the UK does not improve how it hosts clinical trials, according to a new report from Alzheimer’s Research UK.
Brain Health: A new way to think about dementia risk reduction
January 2021
How we can use ‘brain health’ to transform the public’s attitude towards dementia risk reduction.
Delivering Dementia – Plan to find life-changing treatments
January 2020
Alzheimer’s Research UK has called on government to invest in six priority research areas, which will help to deliver a life-changing treatment for dementia.
Detecting and diagnosing Alzheimer’s disease
December 2019
Our report reveals public attitudes to early diagnosis of Alzheimer’s.
Dementia Attitudes Monitor: Wave 1 (2018)
January 2019
A comprehensive review of public attitudes towards dementia and research, identifying key misperceptions and opportunities for shaping public attitudes towards the condition.
No time to lose: An action plan for dementia
September 2018
The five actions government can take to improve the lives of people with dementia.
Brain Health consensus statement
Driving progress in dementia risk reduction by rallying health stakeholders around ‘brain health’.
